Hexham, UK, 08 November 2021: RareCan, a novel company accelerating research into rare cancers, today announced it has partnered with leading UK-based charity, Blood Cancer
RareCan receives approval from NHS Research Ethics Committee to establish vital BioResource at Newcastle University Hexham, UK, 25 October 2021: RareCan, a novel company accelerating
September Team Meeting For those of you who are new to RareCan, you may not know that we recently celebrated our First Birthday. Since RareCan
Pravjoth’s Rare Cancer Journey Pravjoth was diagnosed with a rare cancer aged 17. Having recently graduated from university, she is now an Entrepreneur. Her ambition
RareCan appoints Dr Anita Cooper as Non-Executive Director Hexham, UK, 2nd August 2021: RareCan, a new and innovative company accelerating research into rare cancers, today
Is my Cancer Rare? The honest answer is, ‘It depends how closely you look.’ Until recently the only way of splitting cancers into various types
RareCan Newsletter Firstly, thank you to everyone who has signed up to RareCan to become a member, we would not be anywhere without your support
Cancer Survival Rates At RareCan, we find it really frustrating that research into rare cancer is limited and that the survival rate for people with
Jo’s Malignant Melanoma Story ‘Being diagnosed with a Malignant Melanoma in my early 40’s was not part of my life plan.’ A difficult experience with
Celebrating 100 Members! 100 members is a significant milestone in the development of RareCan. It is 100 people with cancer, predominantly GIST or PAWS GIST
RareCan Limited is a company registered in England, number 12844377. Registered office address: 8 Park Avenue, Hexham, England, NE46 3EN.
